DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Roth Capital Initiates Coverage On NextCure with Buy Rating, Announces $80 Price Target

Roth Capital analyst Tony Butler initiates coverage on NextCure (NASDAQ:NXTC) with a Buy rating and a $80 price target.

Benzinga · 03/02/2020 13:27

Roth Capital analyst Tony Butler initiates coverage on NextCure (NASDAQ:NXTC) with a Buy rating and a $80 price target.